About phip
We subsequently designed a more unique probe, [18F]CFA, which was Utilized in The existing examine to evaluate dCK exercise in tumors when addressed with a little molecule dCK inhibitor. This probe is additionally being studied in a very clinical demo at our establishment to evaluate variations in dCK activity adhering to most cancers immunotherapy